Marine Natural Products in Anti-obesity and Metabolic Syndrome
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine-Derived Ingredients for Drugs, Cosmeceuticals and Nutraceuticals".
Deadline for manuscript submissions: closed (31 May 2024) | Viewed by 443
Special Issue Editor
Special Issue Information
Dear Colleagues,
Metabolic syndrome (MS) is a collection of multiple risk factors for type 2 diabetes mellitus and cardiovascular disease, including obesity, insulin resistance, hyperglycemia, dyslipidemia, hypertension and hyperuricemia. It is not a disease but a common complex entity that represents a worldwide epidemic and major public health concern, affecting approximately 30% of adults globally. Currently, the accurate pathogenesis of MS is still unclear, with central obesity and insulin resistance playing critical roles in initiating and perpetuating its pathologic features. To date, lifestyle interventions are still the main therapeutic strategies for the treatment of MS. Nowadays, increasing evidence suggests that marine natural products have effective ameliorative effects on MS-related metabolic abnormalities, explain their emergence as a potential preventive strategy for the syndrome. For this Special Issue, we invite original research papers and reviews on the current knowledge of the protective effects of marine natural products on metabolic syndrome and related metabolic abnormalities.
Dr. Xiang Gao
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- marine natural products
- metabolic syndrome
- anti-obesity
- cardiovascular disease
- diabetes mellitus
- dyslipidemia
- hypertension
